相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
Eugenio Montini et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
From bone marrow to microglia: barriers and avenues
Nathalie Davoust et al.
TRENDS IN IMMUNOLOGY (2008)
High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR)
Schmidt Manfred et al.
NATURE METHODS (2007)
X-linked adrenoleukodystrophy
Hugo W. Moser et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits mice
Alessandra Biffi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells
M De Palma et al.
BLOOD (2005)
Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein
M Asheuer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
HB Gaspar et al.
LANCET (2004)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice
S Benhamida et al.
MOLECULAR THERAPY (2003)
Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice
W Piacibello et al.
BLOOD (2002)
HIV-1 integration in the human genome favors active genes and local hotspots
ARW Schröder et al.
CELL (2002)
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy
A Pujol et al.
HUMAN MOLECULAR GENETICS (2002)
Targeting gene-modified hematopoietic cells to the central nervous system:: Use of green fluorescent protein uncovers microglial engraftment
J Priller et al.
NATURE MEDICINE (2001)
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
MA Kay et al.
NATURE MEDICINE (2001)
Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy
E Shapiro et al.
LANCET (2000)
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
M Cavazzana-Calvo et al.
SCIENCE (2000)